BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
We remain positive on healthcare space and expect strong growth recovery in non-Covid-19 business along with potential margin improvement from cost-control initiatives undertaken in the past few months.
Sector companies under our coverage witnessed average appreciation of 37% in stock prices over the last year largely driven by diagnostic companies.
Key notable points for CY21-
1. Recovery in occupancy level including medical tourists for hospitals,
2. likely improvement in volume growth for diagnostic companies with shift from unorganised market to organised players,
3. incremental business from Covid-19 patients and
4. upward reset of Ebitda margin with partial continuation of cost-control initiatives undertaken during the lockdown.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR